Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

A,-blockers

In designing a continuous plant, therefore, it is essential to establish the measurement and control strategy based on an understanding of which critical aspects are indicative of good or poor plant operation, and how deviation of these measurements can be exploited to perform a corrective process control action. Estabhshing suitable on-hne real-time measurement techniques may be a blocker to the implementation of continuous processing. In contrast, implementation of a successful measurement and control strategy may be the enabler for improved product yields and product quahty. [Pg.326]

Centrally acting agents (clonidine, methyldopa, and reserpine) Spironolactone a-Blockers Lipid medications Gemfibrozil Antidepressants... [Pg.782]

Nitric oxide (NO) is an intercellular signaling molecule that can inhibit neuronal energy production (Brorson et al., 1999 Malefic et al., 2004). It has been found that NO donors cause large increases in extracellular adenosine in cultures of forebrain neurons (Rosenberg et al., 2000). These were shown to be caused by NO release, and the accumulation of adenosine was not blocked by probenecid (ENT blocker) or GMP (a blocker of AMP hydrolysis), suggesting that adenosine was likely of intracellular origin. Indeed, it was found that NO donors caused a decrease in intracellular ATP and the inhibition of adenosine kinase activity, possibly due to the rise in adenosine. [Pg.346]

Fig. 4 Schematic representation of the diffuse reflectance sampling accessory. Key A, blocker device to eliminate specular reflectance B, path of IR beam. Fig. 4 Schematic representation of the diffuse reflectance sampling accessory. Key A, blocker device to eliminate specular reflectance B, path of IR beam.
Patients who had been prescribed calcium channel blockers for hypertension who are not receiving //-blockers and who do not have a contraindication should have the calcium channel blocker discontinued and a //-blocker initiated. [Pg.66]

The a-blockers have favorable effects (decreased low-density lipoprotein cholesterol and increased high-density lipoprotein cholesterol levels). However, because they do not reduce CV risk as effectively as thiazide diuretics, this benefit is not clinically applicable. [Pg.140]

The combinatorial approach, which combines a blocker of anti-apoptotic signaling with a stimulator of stress signaling, could prove to be a general approach. [Pg.11]

Hirst Yes, I have. I have stimulated the sympathetic changes with physiological frequencies of stimulation, loaded the animals with benextramine, an irreversible a blocker, and I can see no changes in the neuronal responses although the responses to circulating catecholamines are abolished. [Pg.225]

In fact the benzdioxepine is more of a stimulant than a blocker. In the syrosingopinised rat test a full agonist such as isoprenaline only produces an increase in heart rate of 200-210 beats/min. [Pg.12]

Ketamine acts as a blocker (or antagonist ) of the NMDA receptor. PCP also acts as an antagonist of the NMDA receptor, as does alcohol, although much less potently. NMDA receptors are present in numerous brain regions, and ketamine is thought to produce its effects by blocking NMDA receptors in a number of brain regions, as shown in Table 6.1. [Pg.67]

In benign hyperplasia of the prostate, a-blockers (terazosin, alfuzosin) may serve to lower tonus of smooth musculature in the prostatic region and thereby facilitate micturition (p. 252). [Pg.90]

Drugs for the control of hypertensive crises include nifedipine (capsule, to be chewed and swallowed), nitroglycerin (sublingually), clonidine (p.o. or i.v., p. 96), dihydralazine (i.v.), diazoxide (i.v.), fenoldopam (by infusion, p. 114) and sodium nitroprusside (p. 120, by infusion). The nonselective a-blocker phentolamine (p. 90) is indicated only in pheochromocytoma... [Pg.312]

Compounds capable of blocking a-adrenergic receptive regions by preventing various agonists from acting on them are called a-blockers. [Pg.167]


See other pages where A,-blockers is mentioned: [Pg.430]    [Pg.24]    [Pg.156]    [Pg.142]    [Pg.208]    [Pg.997]    [Pg.1969]    [Pg.1990]    [Pg.159]    [Pg.282]    [Pg.785]    [Pg.1213]    [Pg.204]    [Pg.504]    [Pg.221]    [Pg.720]    [Pg.211]    [Pg.225]    [Pg.184]    [Pg.505]    [Pg.66]    [Pg.66]    [Pg.79]    [Pg.80]    [Pg.276]    [Pg.90]    [Pg.90]    [Pg.90]    [Pg.312]    [Pg.15]    [Pg.1073]    [Pg.1436]    [Pg.168]   
See also in sourсe #XX -- [ Pg.90 ]

See also in sourсe #XX -- [ Pg.3 , Pg.28 ]




SEARCH



A-Adrenergic blockers

A-Adrenergic blockers adverse effects

A-Adrenergic blockers specific agents

Sodium channel blockers as antiarrhythmics

TNF-a blockers

© 2024 chempedia.info